Sumitomo Chemical (SOMMF) Earnings Preview: EPS Seen at -$0.12 on Margin Pressure

Sumitomo Chemical Company, Limited (SOMMF) reports earnings on May 14, 2026, with analysts expecting a loss of $0.12 per share and revenue of $3.88 billion. The Japanese chemicals giant faces headwinds from margin compression across its diversified portfolio, which spans synthetic resins, semiconductors, crop sciences, and pharmaceuticals. With a market cap of $5.53 billion and trading at $3.375, SOMMF has shown volatility over the past year. Investors will focus on whether the company can stabilize profitability and manage costs effectively in a challenging global chemicals environment.

Earnings Estimates and Historical Performance

Analysts project SOMMF will report a loss of $0.12 per share for the upcoming quarter, a significant shift from recent mixed results. The revenue estimate stands at $3.88 billion, slightly below the prior quarter’s $3.90 billion but above the $3.63 billion reported in the previous period.

Recent Earnings Trend

SOMMF’s earnings history reveals inconsistent profitability. In February 2026, the company beat EPS expectations with $0.1859 versus an estimate of -$0.01107, while revenue came in at $3.90 billion against a $3.73 billion estimate. However, in August 2025, SOMMF missed on EPS with -$0.01909 versus -$0.00509 expected, though revenue exceeded at $3.63 billion versus $3.90 billion estimated. This pattern suggests operational challenges in converting revenue to earnings.

What the Loss Estimate Means

The projected $0.12 loss indicates margin pressure across SOMMF’s business segments. The company’s net profit margin stands at 4.06% trailing twelve months, suggesting thin profitability. A loss this quarter would mark the third negative EPS result in five quarters, signaling persistent challenges in cost management and pricing power within the chemicals sector.

Key Metrics and Financial Health

SOMMF trades at a price-to-earnings ratio of 8.88 and a price-to-sales ratio of 0.36, indicating the market values the company at a discount to historical averages. The stock’s current price of $3.375 sits near its 52-week low of $2.75 and well below the year high of $3.42.

Balance Sheet Strength

The company maintains a current ratio of 1.57, showing adequate short-term liquidity. However, debt-to-equity stands at 1.19, reflecting moderate leverage. Operating cash flow per share of $124.85 demonstrates the company generates solid cash despite earnings volatility. Free cash flow per share of $56.86 provides flexibility for dividends and investments, with a dividend yield of 2.60%.

Profitability Metrics

Return on equity of 10.39% and return on assets of 2.79% are modest but acceptable for a diversified chemicals company. The company’s gross profit margin of 29.76% shows reasonable pricing on raw materials, but operating margins of 6.44% reveal cost pressures in manufacturing and distribution. These metrics suggest SOMMF struggles to convert gross profits into operating income.

What Investors Should Watch

Investors should focus on segment performance, cost management initiatives, and guidance for the remainder of 2026. SOMMF’s diversified business—spanning Essential Chemicals, Energy & Functional Materials, IT-Related Chemicals, Health & Crop Sciences, and Pharmaceuticals—means earnings depend on multiple end markets.

Segment Breakdown

The IT-Related Chemicals segment, which supplies materials for semiconductors and displays, faces cyclical demand. Energy & Functional Materials, including lithium-ion battery components, should benefit from EV growth. Health & Crop Sciences provides defensive earnings through agricultural demand. Watch for which segments drove the expected loss and whether management expects improvement.

Cost and Pricing Dynamics

With operating margins compressed at 6.44%, management commentary on pricing actions and cost reduction programs will be critical. The chemicals industry faces raw material volatility and energy costs. Listen for updates on production efficiency, capacity utilization, and whether SOMMF can pass costs to customers or must absorb them.

Meyka AI Grade and Analyst Outlook

Meyka AI rates SOMMF with a grade of B+. This grade factors in S&P 500 benchmark comparison, sector performance, financial growth, key metrics, and analyst consensus. The score of 70.84 reflects a balanced view: the company has solid fundamentals but faces near-term profitability challenges.

What the Grade Means

The B+ rating suggests SOMMF is fairly valued at current levels but not a compelling buy. The company’s 10.39% return on equity and 2.60% dividend yield appeal to income investors, while the low P/E of 8.88 attracts value seekers. However, the projected loss and margin pressure warrant caution. Investors should wait for management guidance before adding positions.

Beat or Miss Prediction

Based on historical performance, SOMMF has beaten on revenue in 3 of the last 4 quarters but missed on EPS in 2 of 4. The current loss estimate is conservative, suggesting a potential beat if the company reports a smaller loss or narrow profit. However, revenue could come in below the $3.88 billion estimate if demand softens. Watch for any guidance cuts, which would signal deeper challenges ahead.

Final Thoughts

Sumitomo Chemical reports earnings May 14 with expected $0.12 loss per share and $3.88 billion revenue. The company faces margin compression and cyclical market exposure, but strong cash generation, 8.88 P/E valuation, and 2.60% dividend provide support. Meyka AI’s B+ grade reflects balanced fundamentals with near-term headwinds. Key focus areas include segment trends, cost management, and 2026 guidance. An EPS beat or positive guidance could drive gains, while revenue misses or margin deterioration would pressure the stock. The earnings report will reveal if challenges are temporary or structural.

FAQs

Disclaimer:

Stock markets involve risks. This content is for informational purposes only. Earnings estimates are analyst projections and not guarantees of actual results. Past performance does not guarantee future results. Meyka AI PTY LTD provides market analysis and data insights, not financial advice. Always conduct your own research and consider consulting a licensed financial advisor.